Agency Forms Undergoing Paperwork Reduction Act Review, 78874-78875 [2024-21981]
Download as PDF
<![CDATA[
78874
Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than October 11, 2024.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414.
Comments can also be sent
electronically to
Comments.applications@chi.frb.org:
1. Gregory S. Jeffers, Urbana, Illinois;
and Tod A. Jeffers, Natalie A. Jeffers,
Kathryn G. Jeffers, Joseph T. Jeffers, and
Karen A. Jeffers, all of Bethany, Illinois;
as members of the Jeffers Family Group,
a group acting in concert, to retain
voting shares of Scott Bancshares, Inc.,
and thereby indirectly retain voting
shares of Scott State Bank, both of
Bethany, Illinois.
B. Federal Reserve Bank of
Minneapolis (Mark Rauzi, Vice
President), 90 Hennepin Avenue,
Minneapolis, Minnesota 55480–0291.
Comments can also be sent
electronically to MA@mpls.frb.org:
1. Barrett Doss, Los Angeles,
California; to join the Skalicky Family
Group, a group acting in concert, to
acquire voting shares of Stearns
Financial Services, Inc., Saint Cloud,
Minnesota, and thereby indirectly
acquire voting shares of Stearns Bank
National Association, Saint Cloud,
Minnesota, and Stearns Bank of Upsala,
National Association, Upsala,
Minnesota.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Associate Secretary of the Board.
[FR Doc. 2024–22107 Filed 9–25–24; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-24–24HP]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Compliance
Attestation Statement for the
Framework for Nucleic Acid Synthesis
Screening’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on July 24,
2024 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
Form name
Providers and manufacturers of synthetic nucleic acids and bench top nucleic acid synthesis equipment.
Annual Provider and Manufacturer Self-Attestation Statement.
17:11 Sep 25, 2024
Jkt 262001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Proposed Project
Compliance Attestation Statement for
the Framework for Nucleic Acid
Synthesis Screening—New—Office of
Science (OS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The purpose of this Attestation Form
is to assist providers of synthetic
nucleic acids (Providers) and
manufacturers of benchtop nucleic acid
synthesis equipment (Manufacturers) in
making an attestation that they are
performing due diligence in screening
product orders and customers consistent
with the expectations outlaid in the
federal Framework for Nucleic Acid
Synthesis Screening (Framework).
While Providers and Manufacturers may
choose a different mode to make such
an attestation, this Attestation Form
serves as a valid template. This
statement of attestation will provide the
U.S. Federal Government and
researchers using any United States
Government life sciences research
award (e.g., research grant, contract,
etc.) for procurement of synthetic
nucleic acids or benchtop nucleic acid
synthesis equipment reasonable
assurance that Providers and
Manufacturers are complying with the
Framework.
CDC requests OMB approval for an
estimated 20 annual burden hours.
There are no costs to respondents other
than their time to participate.
Estimated Annualized Burden Hours
Number of
respondents
Type of respondents
VerDate Sep<11>2014
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\26SEN1.SGM
60
26SEN1
Number of
responses per
respondent
1
Average
burden per
response
(in hours)
20/60
Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–21981 Filed 9–25–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–2744]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
November 25, 2024.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:11 Sep 25, 2024
Jkt 262001
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–2744—End Stage Renal Disease
Annual Facility Survey Form
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collections
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: End Stage Renal
Disease Annual Facility Survey Form;
Use: The Program Management and
Medical Information System (PMMIS)
collects provider-specific and aggregate
patient population data on ESRD
beneficiaries treated by dialysis and
transplant providers. Each facility
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
78875
certification/survey record represents
one provider. The CMS–2744 captures
certification and other information
about ESRD facilities approved by
Medicare to provide kidney dialysis and
transplant services. Additionally, the
CMS–2744 captures activities performed
during the calendar year, as well as
aggregate year-end population counts
for both Medicare beneficiaries and nonMedicare patients. The data elements
include basic provider information such
as provider certification and type of
ownership; aggregated dialysis patient
data such as the number of patients,
number of deaths, and number of
patients receiving different types of
dialysis; dialysis treatment data; kidney
transplant data such as number of
transplants, type of transplants, and
number of patients awaiting transplants;
and the total number of each method
used to obtain kidneys for transplants.
The CMS–2744 collects data on
hemodialysis patients dialyzing,
vocational rehabilitation, and staffing.
The accuracy of the Facility Survey
depends on complete reporting by each
facility.
Modifications to the CMS–2744 are (a)
collection of days the dialysis facility is
open; (b) shifts dialysis is provided; (c)
adding ‘‘failed’’ to ‘‘return after
transplant’’ for clarity; (d) removing
questions related to vocational
rehabilitation; and (e) aligning
instructions with revisions. Form
Number: CMS–2744 (OMB control
number: 0938–0447); Frequency: Yearly;
Affected Public: Business or other forprofit, Not-for-profit institutions;
Number of Respondents: 7,726; Total
Annual Responses: 7,726; Total Annual
Hours: 15,452. (For policy questions
regarding this collection contact
Christina Goatee at 410–786–6689.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–21978 Filed 9–25–24; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10856]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
AGENCY:
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 89, Number 187 (Thursday, September 26, 2024)]
[Notices]
[Pages 78874-78875]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21981]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-24HP]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Compliance Attestation Statement for the
Framework for Nucleic Acid Synthesis Screening'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on July 24, 2024 to obtain comments from the
public and affected agencies. CDC did not receive comments related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Compliance Attestation Statement for the Framework for Nucleic Acid
Synthesis Screening--New--Office of Science (OS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The purpose of this Attestation Form is to assist providers of
synthetic nucleic acids (Providers) and manufacturers of benchtop
nucleic acid synthesis equipment (Manufacturers) in making an
attestation that they are performing due diligence in screening product
orders and customers consistent with the expectations outlaid in the
federal Framework for Nucleic Acid Synthesis Screening (Framework).
While Providers and Manufacturers may choose a different mode to make
such an attestation, this Attestation Form serves as a valid template.
This statement of attestation will provide the U.S. Federal Government
and researchers using any United States Government life sciences
research award (e.g., research grant, contract, etc.) for procurement
of synthetic nucleic acids or benchtop nucleic acid synthesis equipment
reasonable assurance that Providers and Manufacturers are complying
with the Framework.
CDC requests OMB approval for an estimated 20 annual burden hours.
There are no costs to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Providers and manufacturers of Annual Provider and 60 1 20/60
synthetic nucleic acids and bench top Manufacturer Self-
nucleic acid synthesis equipment. Attestation Statement.
----------------------------------------------------------------------------------------------------------------
[[Page 78875]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-21981 Filed 9-25-24; 8:45 am]
BILLING CODE 4163-18-P
